229 related articles for article (PubMed ID: 26905561)
1. Intravenous Thrombolysis and Risk Factors for Ischemic Stroke.
Shrestha S; Poudel RS; Thapa LJ; Khatiwada D
JNMA J Nepal Med Assoc; 2014; 52(193):745-50. PubMed ID: 26905561
[TBL] [Abstract][Full Text] [Related]
2. The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST.
Flint AC; Gupta R; Smith WS; Kamel H; Faigeles BS; Cullen SP; Rao VA; Bath PM; Wahlgren N; Ahmed N; Donnan GA;
Int J Stroke; 2014 Aug; 9(6):705-10. PubMed ID: 25042855
[TBL] [Abstract][Full Text] [Related]
3. Rationale, design, and progress of the ENhanced Control of Hypertension ANd Thrombolysis strokE stuDy (ENCHANTED) trial: An international multicenter 2 × 2 quasi-factorial randomized controlled trial of low- vs. standard-dose rt-PA and early intensive vs. guideline-recommended blood pressure lowering in patients with acute ischaemic stroke eligible for thrombolysis treatment.
Huang Y; Sharma VK; Robinson T; Lindley RI; Chen X; Kim JS; Lavados P; Olavarría V; Arima H; Fuentes S; Nguyen HT; Lee TH; Parsons MW; Levi C; Demchuk AM; Bath PM; Broderick JP; Donnan GA; Martins S; Pontes-Neto OM; Silva F; Pandian J; Ricci S; Stapf C; Woodward M; Wang J; Chalmers J; Anderson CS;
Int J Stroke; 2015 Jul; 10(5):778-88. PubMed ID: 25832995
[TBL] [Abstract][Full Text] [Related]
4. [Thrombolytic therapy for acute ischemic stroke. Experience of SITS (Safe Implementation of Thrombolysis in Stroke) register].
Rodríguez-Yáñez M; Alvarez-Sabín J; Dávalos A; Díez-Tejedor E; Castillo J
Neurologia; 2009 Jun; 24(5):288-91. PubMed ID: 19642029
[TBL] [Abstract][Full Text] [Related]
5. Early neurological deterioration within 24 hours after intravenous rt-PA therapy for stroke patients: the Stroke Acute Management with Urgent Risk Factor Assessment and Improvement rt-PA Registry.
Mori M; Naganuma M; Okada Y; Hasegawa Y; Shiokawa Y; Nakagawara J; Furui E; Kimura K; Yamagami H; Kario K; Okuda S; Koga M; Minematsu K; Toyoda K
Cerebrovasc Dis; 2012; 34(2):140-6. PubMed ID: 22854333
[TBL] [Abstract][Full Text] [Related]
6. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
[TBL] [Abstract][Full Text] [Related]
7. Intravenous thrombolysis in young stroke patients: results from the SITS-ISTR.
Toni D; Ahmed N; Anzini A; Lorenzano S; Brozman M; Kaste M; Mikulik R; Putaala J; Wahlgren N;
Neurology; 2012 Mar; 78(12):880-7. PubMed ID: 22402853
[TBL] [Abstract][Full Text] [Related]
8. Utilization of intravenous thrombolysis in 3-4.5 hours: analysis of the Minnesota stroke registry.
Tekle WG; Chaudhry SA; Hassan AE; Peacock JM; Lakshminarayan K; Tsai A; Luepker R; Anderson DC; Qureshi AI
Cerebrovasc Dis; 2012; 34(5-6):400-5. PubMed ID: 23221276
[TBL] [Abstract][Full Text] [Related]
9. Symptomatic intracerebral hemorrhage after intravenous thrombolysis in Chinese patients: comparison of prediction models.
Li M; Wang-Qin RQ; Wang YL; Liu LB; Pan YS; Liao XL; Wang YJ; Xu AD
J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1235-43. PubMed ID: 25891755
[TBL] [Abstract][Full Text] [Related]
10. Thrombolysis for acute ischemic stroke--our experiences as part of SITS-MOST.
Roje-Bedeković M; Vargek-Solter V; Corić L; Sabolek K; Breitenfeld T; Supanc V; Demarin V
Acta Clin Croat; 2009 Sep; 48(3):287-93. PubMed ID: 20055250
[TBL] [Abstract][Full Text] [Related]
11. Intravenous thrombolysis for acute ischemic stroke in the 3- to 4·5-hour window--the Malabar experience.
Salam KA; Ummer K; Pradeep Kumar VG; Noone ML
Int J Stroke; 2014 Jun; 9(4):426-8. PubMed ID: 23981667
[TBL] [Abstract][Full Text] [Related]
12. Nonatrial Fibrillation was Associated With Early Neurological Improvement After Intravenous Thrombolysis With rt-PA in Patients With Acute Ischemic Stroke.
Liu J; Huang J; Xu H; Dai H
Neurologist; 2020 Mar; 25(2):28-32. PubMed ID: 32132497
[TBL] [Abstract][Full Text] [Related]
13. Thrombolytic therapy for acute stroke in the United Kingdom: experience from the safe implementation of thrombolysis in stroke (SITS) register.
Lees KR; Ford GA; Muir KW; Ahmed N; Dyker AG; Atula S; Kalra L; Warburton EA; Baron JC; Jenkinson DF; Wahlgren NG; Walters MR;
QJM; 2008 Nov; 101(11):863-9. PubMed ID: 18694900
[TBL] [Abstract][Full Text] [Related]
14. TESPI (Thrombolysis in Elderly Stroke Patients in Italy): a randomized controlled trial of alteplase (rt-PA) versus standard treatment in acute ischaemic stroke in patients aged more than 80 years where thrombolysis is initiated within three hours after stroke onset.
Lorenzano S; Toni D;
Int J Stroke; 2012 Apr; 7(3):250-7. PubMed ID: 22292526
[TBL] [Abstract][Full Text] [Related]
15. Intravenous thrombolysis for acute ischemic stroke: the Malabar experience 2003 to 2008.
Salam KA; Ummer K; Kumar VG; Noone ML; Laila A; Ragini J
J Clin Neurosci; 2009 Oct; 16(10):1276-8. PubMed ID: 19570685
[TBL] [Abstract][Full Text] [Related]
16. The prospects and predicaments of intravenous rt-PA in childhood ischemic stroke.
Behrouz R
Expert Rev Neurother; 2014 Mar; 14(3):255-9. PubMed ID: 24491039
[TBL] [Abstract][Full Text] [Related]
17. Relationship of blood pressure, antihypertensive therapy, and outcome in ischemic stroke treated with intravenous thrombolysis: retrospective analysis from Safe Implementation of Thrombolysis in Stroke-International Stroke Thrombolysis Register (SITS-ISTR).
Ahmed N; Wahlgren N; Brainin M; Castillo J; Ford GA; Kaste M; Lees KR; Toni D;
Stroke; 2009 Jul; 40(7):2442-9. PubMed ID: 19461022
[TBL] [Abstract][Full Text] [Related]
18. The Belgian experience with intravenous thrombolysis for acute ischemic stroke.
Vanacker P; Thijs V; Peeters A; Bruneel B; Laloux P; Druwé P; De Deyn P; Ahmed N; Wahlgren N; Vanhooren G;
Acta Neurol Belg; 2010 Jun; 110(2):157-62. PubMed ID: 20873445
[TBL] [Abstract][Full Text] [Related]
19. Intravenous thrombolysis in acute ischemic stroke: standard and potential future applications.
Haršány M; Tsivgoulis G; Alexandrov AV
Expert Rev Neurother; 2014 Aug; 14(8):879-92. PubMed ID: 24984941
[TBL] [Abstract][Full Text] [Related]
20. Intravenous recombinant tissue plasminogen activator for acute stroke in Poland: an analysis based on the Safe Implementation of Thrombolysis in Stroke (SITS) Registry.
Kobayashi A; Czlonkowska A; Ahmed N; Romanowicz S; Glonek M; Nyka WM; Opala G; Wahlgren N;
Acta Neurol Scand; 2010 Oct; 122(4):229-36. PubMed ID: 19919643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
